Bangladesh vs Pakistan: Access to anti-retroviral drugs, female
Bangladesh
33.0%
in 2024
Pakistan
24.0%
in 2024
Bangladesh rank
133rd
Pakistan rank
136th
Access to anti-retroviral drugs, female over time
- Bangladesh
- Pakistan
How they compare
Bangladesh currently reports 33.0% against 24.0% in Pakistan, a difference of 9.0%.
That makes Bangladesh's figure about 1.4 times Pakistan's.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Pakistan ahead.
Bangladesh ranks 133rd and Pakistan ranks 136th of 141 countries.
Across the 3 decades both report, Bangladesh averaged higher in 2 and Pakistan in 1.
Head to head by decade
| Decade | Bangladesh | Pakistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.7% | 2.4% | 0.7% | Pakistan |
| 2010s | 16.0% | 6.9% | 9.1% | Bangladesh |
| 2020s | 30.0% | 17.8% | 12.2% | Bangladesh |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Bangladesh or Pakistan?
- Bangladesh, at 33.0% against 24.0% in Pakistan as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Bangladesh and Pakistan?
- 9.0%, with Bangladesh ahead.
- How many years of comparable data are there for Bangladesh and Pakistan?
- 25 years are reported by both, from 2000 to 2024.
- How do Bangladesh and Pakistan rank globally for access to anti-retroviral drugs, female?
- Bangladesh ranks 133rd and Pakistan ranks 136th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.